Impact of AV2 Antiviral Drug on the Treatment of HPV-associated Lesions of the Uterine Cervix

NCT02346227 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

327

Enrollment

OTHER

Sponsor class

Conditions

Uterine Cervical Dysplasia
Papillomavirus Infections

Interventions

DRUG: AV2
DRUG: Placebo

Sponsor

Jean-Pierre Van geertruyden

Collaborators

[object Object]
[object Object]